The decreased proliferative potential of pancreatic cancer associated with C4orf47 expression suggests that C4orf47 expression may be a good prognostic biomarker for Stage I pancreatic cancer, but conversely, the dormant state of the cancer cells may also result in differences in C4orf47 expression. The gene discussed is CFAP96; the disease is familial pancreatic carcinoma.